Celldex Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -48.4% | -48.4% | -33.5% |
| FY2017 | -39.4% | -39.4% | -29.5% |
| FY2018 | -121.9% | -121.9% | -97.0% |
| FY2019 | -54.1% | -54.1% | -41.4% |
| FY2020 | -28.6% | -28.6% | -25.3% |
| FY2021 | -16.8% | -16.8% | -15.9% |
| FY2022 | -34.4% | -34.4% | -31.8% |
| FY2023 | -33.0% | -33.0% | -30.4% |
| FY2024 | -21.1% | -21.1% | -19.9% |
| FY2025 | -49.1% | -49.1% | -44.4% |